Review



h3k4me1  (EpiCypher)


Bioz Verified Symbol EpiCypher is a verified supplier
Bioz Manufacturer Symbol EpiCypher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    EpiCypher h3k4me1
    (A) Genome-wide matrix of topologically associated domains (TADs) shows that most interactions are intrachromosomal (diagonal intensity pattern indicates each chromosome plotted against itself). A unique interaction pattern between chromosomes 1p and 7q (black arrow) was observed in KT-47R1 but not in KT-47PT. (B) Hi-C identified an interchromosomal interaction between chromosome 1p32.3 ( GLIS1 locus) and chromosome 7q21 ( ABCB1 locus, black arrow) in KT-47R1. The light red vertical line marks the boundary between interacting regions of chromosomes 1 (right) and 7 (left). Red arcs indicate interactions between chromosomes 1 and 7 in KT-47R1, absent in KT-47PT (no blue arcs crossing the boundary). RNA-seq reads confirm upregulation of ABCB1 (black arrow) in KT-47R1. (C) CUT&Tag analysis shows <t>H3K4me1</t> peaks within the interacting region of chromosome 1p32.3. Peaks are present in both KT-47PT and KT-47R1, but the chromatin interaction occurs only in KT-47R1. (D) FISH 1p32.3 break-apart analysis demonstrates no translocation involving 1p32.3 in KT-47PT, KT-47 pre-resistance, KT-47R1, or KT-47R2. Scale bars, 5 μm. (E) Chromosome 1 and 7 painting analysis indicated increased interaction (colocalization) between chromosomes 1 and 7 in KT-47R1 (48%) and KT-47R2 (48%) when compared to KT-47PT (19%) and KT-47PR (25%). Scale bars, 10 μm. n = 2 samples per group.
    H3k4me1, supplied by EpiCypher, used in various techniques. Bioz Stars score: 95/100, based on 43 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/13-0055/H3K27me3+Antibody%2C+SNAP-Certified+for+CUT%26RUN+and+CUT%26Tag/pmc13103949-451-12-13
    Average 95 stars, based on 43 article reviews
    h3k4me1 - by Bioz Stars, 2026-11
    95/100 stars

    Images

    1) Product Images from "Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor"

    Article Title: Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor

    Journal: Cell reports

    doi: 10.1016/j.celrep.2026.117063

    (A) Genome-wide matrix of topologically associated domains (TADs) shows that most interactions are intrachromosomal (diagonal intensity pattern indicates each chromosome plotted against itself). A unique interaction pattern between chromosomes 1p and 7q (black arrow) was observed in KT-47R1 but not in KT-47PT. (B) Hi-C identified an interchromosomal interaction between chromosome 1p32.3 ( GLIS1 locus) and chromosome 7q21 ( ABCB1 locus, black arrow) in KT-47R1. The light red vertical line marks the boundary between interacting regions of chromosomes 1 (right) and 7 (left). Red arcs indicate interactions between chromosomes 1 and 7 in KT-47R1, absent in KT-47PT (no blue arcs crossing the boundary). RNA-seq reads confirm upregulation of ABCB1 (black arrow) in KT-47R1. (C) CUT&Tag analysis shows H3K4me1 peaks within the interacting region of chromosome 1p32.3. Peaks are present in both KT-47PT and KT-47R1, but the chromatin interaction occurs only in KT-47R1. (D) FISH 1p32.3 break-apart analysis demonstrates no translocation involving 1p32.3 in KT-47PT, KT-47 pre-resistance, KT-47R1, or KT-47R2. Scale bars, 5 μm. (E) Chromosome 1 and 7 painting analysis indicated increased interaction (colocalization) between chromosomes 1 and 7 in KT-47R1 (48%) and KT-47R2 (48%) when compared to KT-47PT (19%) and KT-47PR (25%). Scale bars, 10 μm. n = 2 samples per group.
    Figure Legend Snippet: (A) Genome-wide matrix of topologically associated domains (TADs) shows that most interactions are intrachromosomal (diagonal intensity pattern indicates each chromosome plotted against itself). A unique interaction pattern between chromosomes 1p and 7q (black arrow) was observed in KT-47R1 but not in KT-47PT. (B) Hi-C identified an interchromosomal interaction between chromosome 1p32.3 ( GLIS1 locus) and chromosome 7q21 ( ABCB1 locus, black arrow) in KT-47R1. The light red vertical line marks the boundary between interacting regions of chromosomes 1 (right) and 7 (left). Red arcs indicate interactions between chromosomes 1 and 7 in KT-47R1, absent in KT-47PT (no blue arcs crossing the boundary). RNA-seq reads confirm upregulation of ABCB1 (black arrow) in KT-47R1. (C) CUT&Tag analysis shows H3K4me1 peaks within the interacting region of chromosome 1p32.3. Peaks are present in both KT-47PT and KT-47R1, but the chromatin interaction occurs only in KT-47R1. (D) FISH 1p32.3 break-apart analysis demonstrates no translocation involving 1p32.3 in KT-47PT, KT-47 pre-resistance, KT-47R1, or KT-47R2. Scale bars, 5 μm. (E) Chromosome 1 and 7 painting analysis indicated increased interaction (colocalization) between chromosomes 1 and 7 in KT-47R1 (48%) and KT-47R2 (48%) when compared to KT-47PT (19%) and KT-47PR (25%). Scale bars, 10 μm. n = 2 samples per group.

    Techniques Used: Genome Wide, Hi-C, RNA Sequencing, Translocation Assay

    Related Articles

    Negative Control:

    Article Title: Systematic mapping of enhancers, silencers, and topological elements with prime editing deletion screens
    Article Snippet: .. We followed the standard protocol for CUT&RUN experiments targeting H3K27me3 (Antibody: EpiCypher 13-0055) and H3K4me3 (Antibody: EpiCypher 13-0060), using Rabbit IgG (Antibody: EpiCypher 13-0042) as a negative control. ..

    Article Title: Histone H4 acetyl-methyllysine marks accessible chromatin that resists compaction
    Article Snippet: Unless otherwise indicated in the figure captions, experiments targeting KDM6A/B were performed by treating HEK293T cells with 5 μM GSK-J4 (MCE, HY-15648B) for either 6 or 24 hrs. .. The following antibodies were used: anti-Kacme (developed with Abcam; 1:1,000 (Western blots), 2.0 μg per rxn (ChIP-seq), 0.5 μg per rxn (CUT&RUN), and 1:1,000 (IF)); anti-H4Kacme (developed with Cocalico Biologicals; 1:1,000 (Western blots) and 2.0 μg per rxn (ChIP-seq); anti-H3K27me3 (EpiCypher, 13-0055, 1:10,000 (Western blots) and 0.5 μg per rxn (CUT&RUN)); anti-H3K4me3 (EpiCypher, 13-0060, 0.5 μg per rxn (CUT&RUN)); anti-H3K27ac (Abcam, ab4729, 2.0 μg per rxn (ChIP-seq)); anti-CTCF (Active Motif, 61311, 1.0 μg per rxn (CUT&RUN)); anti-H4Kac (Abcam, ab233193, 2.0 μg per rxn (ChIP-seq)); anti-H4K5ac (Millipore, 07-327, 1:2,000 (Western blots), 2.0 μg per rxn (ChIP-seq), and 0.5 μg per rxn (CUT&RUN); anti-Histone H3 (phospho S10) (Abcam, ab47297, 1:500 (Western blots)); anti-ACA(Antibodies Inc., 15-234-0001, 1:1,000); anti-IgG negative control (EpiCypher, 13-0042, 0.5 μg per rxn (CUT&RUN)); goat anti-rabbit IgG-HRP (Invitrogen, 31460, 1:2,000 (Western blots)); Alexa Fluor AffiniPure goat anti-rabbit IgG (H+L) (Jackson ImmunoResearch, 1:1,000). .. Histone extracts were collected using the EpiQuik Total Histone Extraction Kit (Epigentek) following the standard kit instructions.

    Activation Assay:

    Article Title: Increased Glycine-N-methyltransferase expression disrupts light-dependent gene expression rhythms in the Drosophila eye.
    Article Snippet: .. The following antibodies were used for CUT&RUN with 20 min of pAG-MNase activation time: anti-IgG (EpiCypher, 13-0042; RRID:AB_ 2923178), anti-H3K4me3 (EpiCypher, 13-0060), anti-H3K4me1 (Abcam, ab8895; RRID:AB_306847), anti-H3K9me3 (Abcam, ab176916; RRID: AB_2797591), anti-H3K27me3 (EpiCypher, 13-0055; RRID:AB_3665059). .. RNA was extracted from five larvae using the Zymoprep Direct-zol RNA MicroPrep kit (Zymo Research, R2050).

    Western Blot:

    Article Title: Histone H4 acetyl-methyllysine marks accessible chromatin that resists compaction
    Article Snippet: Unless otherwise indicated in the figure captions, experiments targeting KDM6A/B were performed by treating HEK293T cells with 5 μM GSK-J4 (MCE, HY-15648B) for either 6 or 24 hrs. .. The following antibodies were used: anti-Kacme (developed with Abcam; 1:1,000 (Western blots), 2.0 μg per rxn (ChIP-seq), 0.5 μg per rxn (CUT&RUN), and 1:1,000 (IF)); anti-H4Kacme (developed with Cocalico Biologicals; 1:1,000 (Western blots) and 2.0 μg per rxn (ChIP-seq); anti-H3K27me3 (EpiCypher, 13-0055, 1:10,000 (Western blots) and 0.5 μg per rxn (CUT&RUN)); anti-H3K4me3 (EpiCypher, 13-0060, 0.5 μg per rxn (CUT&RUN)); anti-H3K27ac (Abcam, ab4729, 2.0 μg per rxn (ChIP-seq)); anti-CTCF (Active Motif, 61311, 1.0 μg per rxn (CUT&RUN)); anti-H4Kac (Abcam, ab233193, 2.0 μg per rxn (ChIP-seq)); anti-H4K5ac (Millipore, 07-327, 1:2,000 (Western blots), 2.0 μg per rxn (ChIP-seq), and 0.5 μg per rxn (CUT&RUN); anti-Histone H3 (phospho S10) (Abcam, ab47297, 1:500 (Western blots)); anti-ACA(Antibodies Inc., 15-234-0001, 1:1,000); anti-IgG negative control (EpiCypher, 13-0042, 0.5 μg per rxn (CUT&RUN)); goat anti-rabbit IgG-HRP (Invitrogen, 31460, 1:2,000 (Western blots)); Alexa Fluor AffiniPure goat anti-rabbit IgG (H+L) (Jackson ImmunoResearch, 1:1,000). .. Histone extracts were collected using the EpiQuik Total Histone Extraction Kit (Epigentek) following the standard kit instructions.

    Chromatin Immunoprecipitation:

    Article Title: Histone H4 acetyl-methyllysine marks accessible chromatin that resists compaction
    Article Snippet: Unless otherwise indicated in the figure captions, experiments targeting KDM6A/B were performed by treating HEK293T cells with 5 μM GSK-J4 (MCE, HY-15648B) for either 6 or 24 hrs. .. The following antibodies were used: anti-Kacme (developed with Abcam; 1:1,000 (Western blots), 2.0 μg per rxn (ChIP-seq), 0.5 μg per rxn (CUT&RUN), and 1:1,000 (IF)); anti-H4Kacme (developed with Cocalico Biologicals; 1:1,000 (Western blots) and 2.0 μg per rxn (ChIP-seq); anti-H3K27me3 (EpiCypher, 13-0055, 1:10,000 (Western blots) and 0.5 μg per rxn (CUT&RUN)); anti-H3K4me3 (EpiCypher, 13-0060, 0.5 μg per rxn (CUT&RUN)); anti-H3K27ac (Abcam, ab4729, 2.0 μg per rxn (ChIP-seq)); anti-CTCF (Active Motif, 61311, 1.0 μg per rxn (CUT&RUN)); anti-H4Kac (Abcam, ab233193, 2.0 μg per rxn (ChIP-seq)); anti-H4K5ac (Millipore, 07-327, 1:2,000 (Western blots), 2.0 μg per rxn (ChIP-seq), and 0.5 μg per rxn (CUT&RUN); anti-Histone H3 (phospho S10) (Abcam, ab47297, 1:500 (Western blots)); anti-ACA(Antibodies Inc., 15-234-0001, 1:1,000); anti-IgG negative control (EpiCypher, 13-0042, 0.5 μg per rxn (CUT&RUN)); goat anti-rabbit IgG-HRP (Invitrogen, 31460, 1:2,000 (Western blots)); Alexa Fluor AffiniPure goat anti-rabbit IgG (H+L) (Jackson ImmunoResearch, 1:1,000). .. Histone extracts were collected using the EpiQuik Total Histone Extraction Kit (Epigentek) following the standard kit instructions.

    other:

    Article Title: Multiomic screening platform uncovers the impact of histone mutations on chromatin and cell fate
    Article Snippet: CUT&RUN was subsequently performed using the CUTANA ChIC/CUT&RUN Kit (Epicypher, 14-1048).

    Incubation:

    Article Title: Biomarker-driven and gene-enhanced viral therapy for malignant peripheral nerve sheath tumor
    Article Snippet: CUT&RUN Assay and Sequencing: CUT&RUN was performed by EpiCypher Services using the automated CUTANA ChIC/CUT&RUN workflow with 500,000 nuclei per reaction (48 reactions). .. Concanavalin-A-immobilized nuclei (EpiCypher #21-1401) were incubated overnight at 4 °C with antibodies against H3K27me3 (EpiCypher #13-0055), H3K4me3 (EpiCypher #13-0060), or matched IgG control (EpiCypher #13-0042); DNA methylation was profiled using recombinant GST-MeCP2 (EpiCypher #15-2002) followed by anti-GST targeting (EpiCypher #13-0073). .. Chromatin cleavage was performed with pAG-MNase (EpiCypher #15-1016), with 0.5 ng E. coli DNA (EpiCypher #18-1401k) per 500,000 nuclei added for spike-in normalization.

    Control:

    Article Title: Biomarker-driven and gene-enhanced viral therapy for malignant peripheral nerve sheath tumor
    Article Snippet: CUT&RUN Assay and Sequencing: CUT&RUN was performed by EpiCypher Services using the automated CUTANA ChIC/CUT&RUN workflow with 500,000 nuclei per reaction (48 reactions). .. Concanavalin-A-immobilized nuclei (EpiCypher #21-1401) were incubated overnight at 4 °C with antibodies against H3K27me3 (EpiCypher #13-0055), H3K4me3 (EpiCypher #13-0060), or matched IgG control (EpiCypher #13-0042); DNA methylation was profiled using recombinant GST-MeCP2 (EpiCypher #15-2002) followed by anti-GST targeting (EpiCypher #13-0073). .. Chromatin cleavage was performed with pAG-MNase (EpiCypher #15-1016), with 0.5 ng E. coli DNA (EpiCypher #18-1401k) per 500,000 nuclei added for spike-in normalization.

    DNA Methylation Assay:

    Article Title: Biomarker-driven and gene-enhanced viral therapy for malignant peripheral nerve sheath tumor
    Article Snippet: CUT&RUN Assay and Sequencing: CUT&RUN was performed by EpiCypher Services using the automated CUTANA ChIC/CUT&RUN workflow with 500,000 nuclei per reaction (48 reactions). .. Concanavalin-A-immobilized nuclei (EpiCypher #21-1401) were incubated overnight at 4 °C with antibodies against H3K27me3 (EpiCypher #13-0055), H3K4me3 (EpiCypher #13-0060), or matched IgG control (EpiCypher #13-0042); DNA methylation was profiled using recombinant GST-MeCP2 (EpiCypher #15-2002) followed by anti-GST targeting (EpiCypher #13-0073). .. Chromatin cleavage was performed with pAG-MNase (EpiCypher #15-1016), with 0.5 ng E. coli DNA (EpiCypher #18-1401k) per 500,000 nuclei added for spike-in normalization.

    Recombinant:

    Article Title: Biomarker-driven and gene-enhanced viral therapy for malignant peripheral nerve sheath tumor
    Article Snippet: CUT&RUN Assay and Sequencing: CUT&RUN was performed by EpiCypher Services using the automated CUTANA ChIC/CUT&RUN workflow with 500,000 nuclei per reaction (48 reactions). .. Concanavalin-A-immobilized nuclei (EpiCypher #21-1401) were incubated overnight at 4 °C with antibodies against H3K27me3 (EpiCypher #13-0055), H3K4me3 (EpiCypher #13-0060), or matched IgG control (EpiCypher #13-0042); DNA methylation was profiled using recombinant GST-MeCP2 (EpiCypher #15-2002) followed by anti-GST targeting (EpiCypher #13-0073). .. Chromatin cleavage was performed with pAG-MNase (EpiCypher #15-1016), with 0.5 ng E. coli DNA (EpiCypher #18-1401k) per 500,000 nuclei added for spike-in normalization.



    Similar Products

    95
    EpiCypher antibodies against h3k27me3
    A-D) MTS cell viability assays are presented with viability day +6 from infection normalized to uninfected controls. Error bars represent standard error of the mean for biological replicates, where each experiment utilized N = 6 technical replicates per dose. Blue lines and bars correspond to the <t>H3K27me3-deficient</t> condition. Dose-response curves were fitted via non-linear regression, and IC 50 values were compared using the Extra sum-of-squares F test. A) HSV G47Δ demonstrates significantly greater cytotoxicity against all evaluated human MPNST cell lines compared to hTert -immortalized primary human Schwann cells (iHSC 1L), based on IC 50 comparisons (all p <0.001). The mean IC 50 for every tested MPNST cell line is <0.1 MOI. B) In isogenic models of MPNST derived from hTert -immortalized human Schwann cells, SUZ12 knock-out shifts the IC 50 to the left ( p <0.001). C) PRC2-proficient MPNST724 is further sensitized to HSV G47Δ when H3K27me3 is depleted by pharmacologic pretreatment with valemetostat ( p <0.001), while drug pretreatment did not significantly alter the IC 50 in PRC2-deficient S462-TY ( p =0.8). D) S462-TY was engineered to restore SUZ12 under a doxycycline-inducible TET system (TY5005 is the derivative of parental S462-TY). After genetic rescue restoring H3K27me3, the IC 50 of HSV G47Δ significantly shifted rightward ( p <0.001). E) Equally seeded MPNST724 (valemetostat pretreated vs. wildtype) and TY5005 (doxycycline induced vs. wildtype) were infected at 0.01 MOI. Adherent cells were collected at indicated time points, and the percentage of β-galactosidase positive cells was quantified by flow cytometry. Kinetics of HSV G47Δ spread were significantly increased in the H3K27me3-deficient context. By 72 hours, 100% infection coverage was observed in the H3K27me3-deficient condition compared to approximately 10% in the PRC2-proficient condition. Error bars represent SEM for three biological replicates. Statistical significance between PRC2-proficient and deficient conditions at each timepoint was determined using Welch’s t-tests, with p-values adjusted for multiple comparisons (BH procedure) [*: p ≤0.05; **: p ≤0.01; ***: p ≤0.001; ****: p ≤0.0001].
    Antibodies Against H3k27me3, supplied by EpiCypher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/13-0055/H3K27me3+Antibody%2C+SNAP-Certified+for+CUT%26RUN+and+CUT%26Tag/bio_rxiv__64898__2026__10__12__758653-69-11-14
    Average 95 stars, based on 1 article reviews
    antibodies against h3k27me3 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    EpiCypher h3k27me3
    A. Locus plot of the silencer s1, located within an intron of ZCCHC24 (hg19: chr10:81,104,100-81,207,000). Close-up shows the ChromBPNet attribution track, annotated TFBS, and Swap-seq edits within s1. Significance determined by one-sample t-test: red, BH-corrected p < 0.001; gray, not significant. Error bars: 95% CI for the mean. B. qPCR quantification of the effects of s1 edits on PPIF and ZCCHC24 gene expression. qPCR was used to measure the change of PPIF and ZCCHC24 gene expression between WT clones and clones carrying a homozygous Swap-seq edit of s1. Each dot represents results from an independent clone, averaged between three qPCR replicates. Error bars: 95% CI for the mean. C. Validation of the silencer by lentiMPRA. The silencer, in both orientations, was paired with three promoters: PPIF , EF1A , and FTH1 . A sequence lacking predicted TFBS (noTFBS) served as a negative control for basal promoter strength. Significance determined by two-sample t-test: *p < 0.05, **p < 0.01, ***p < 0.001. Error bars: 95% CI for the mean. D. Inhibitor treatment of cells with lentiviral fluorescent reporter construct. Cells were treated with the indicated inhibitors over a 5-day time course and assayed on days 0, 2, 3 and 5. Dots show mean fluorescence intensity (MFI), expressed as fold-change over DMSO controls, averaged across 3 biological replicates. Blue, reporter construct with silencer; gray, EF1A promoter-only control. Significance determined by unpaired two-sided Welch’s t-test: *p < 0.05, **p < 0.01, ns, not significant. Error bars: 95% CI for the mean. E. Genomic tracks of accessibility and histone modifications at the silencer s1 locus in WT and clonal lines carrying s1 deletion. Blue, WT; orange, homozygous edited clones. Top to bottom: ATAC-seq (WT, 4 clones; Edited, 6 clones), H3K4me3 CUT&RUN (WT, 3 clones; Edited, 3 clones), <t>H3K27me3</t> CUT&RUN (WT, 6 clones; Edited, 6 clones), and H3K27ac CUT&RUN (WT, 3 clones; Edited, 3 clones). The scale of H3K27me3 is set such that the maximum matches signal at the exemplary locus enriched with this signal (see fig. S9C ). F. Quantification of ATAC-seq and CUT&RUN signal changes between WT and clones with the s1 edit. Significance determined by Wald z-test: *p < 0.05, **p < 0.01, ***p < 0.001, ns, not significant. Peaks with significant changes highlighted in black. Error bars: 95% CI for the mean. G. Model of silencer s1 mechanism. The silencer depends on HDACs to repress nearby enhancers that regulate PPIF and ZCCHC24 . Deletion of the silencer leads to increased enhancer activities, thereby upregulating PPIF and ZCCHC24 .
    H3k27me3, supplied by EpiCypher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/13-0055/H3K27me3+Antibody%2C+SNAP-Certified+for+CUT%26RUN+and+CUT%26Tag/bio_rxiv__64898__2026__10__08__756856-400-9-11
    Average 95 stars, based on 1 article reviews
    h3k27me3 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    EpiCypher anti h3k27me3
    A. Locus plot of the silencer s1, located within an intron of ZCCHC24 (hg19: chr10:81,104,100-81,207,000). Close-up shows the ChromBPNet attribution track, annotated TFBS, and Swap-seq edits within s1. Significance determined by one-sample t-test: red, BH-corrected p < 0.001; gray, not significant. Error bars: 95% CI for the mean. B. qPCR quantification of the effects of s1 edits on PPIF and ZCCHC24 gene expression. qPCR was used to measure the change of PPIF and ZCCHC24 gene expression between WT clones and clones carrying a homozygous Swap-seq edit of s1. Each dot represents results from an independent clone, averaged between three qPCR replicates. Error bars: 95% CI for the mean. C. Validation of the silencer by lentiMPRA. The silencer, in both orientations, was paired with three promoters: PPIF , EF1A , and FTH1 . A sequence lacking predicted TFBS (noTFBS) served as a negative control for basal promoter strength. Significance determined by two-sample t-test: *p < 0.05, **p < 0.01, ***p < 0.001. Error bars: 95% CI for the mean. D. Inhibitor treatment of cells with lentiviral fluorescent reporter construct. Cells were treated with the indicated inhibitors over a 5-day time course and assayed on days 0, 2, 3 and 5. Dots show mean fluorescence intensity (MFI), expressed as fold-change over DMSO controls, averaged across 3 biological replicates. Blue, reporter construct with silencer; gray, EF1A promoter-only control. Significance determined by unpaired two-sided Welch’s t-test: *p < 0.05, **p < 0.01, ns, not significant. Error bars: 95% CI for the mean. E. Genomic tracks of accessibility and histone modifications at the silencer s1 locus in WT and clonal lines carrying s1 deletion. Blue, WT; orange, homozygous edited clones. Top to bottom: ATAC-seq (WT, 4 clones; Edited, 6 clones), H3K4me3 CUT&RUN (WT, 3 clones; Edited, 3 clones), <t>H3K27me3</t> CUT&RUN (WT, 6 clones; Edited, 6 clones), and H3K27ac CUT&RUN (WT, 3 clones; Edited, 3 clones). The scale of H3K27me3 is set such that the maximum matches signal at the exemplary locus enriched with this signal (see fig. S9C ). F. Quantification of ATAC-seq and CUT&RUN signal changes between WT and clones with the s1 edit. Significance determined by Wald z-test: *p < 0.05, **p < 0.01, ***p < 0.001, ns, not significant. Peaks with significant changes highlighted in black. Error bars: 95% CI for the mean. G. Model of silencer s1 mechanism. The silencer depends on HDACs to repress nearby enhancers that regulate PPIF and ZCCHC24 . Deletion of the silencer leads to increased enhancer activities, thereby upregulating PPIF and ZCCHC24 .
    Anti H3k27me3, supplied by EpiCypher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/13-0055/H3K27me3+Antibody%2C+SNAP-Certified+for+CUT%26RUN+and+CUT%26Tag/bio_rxiv__64898__2026__04__17__718779-217-39-40
    Average 95 stars, based on 1 article reviews
    anti h3k27me3 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    EpiCypher h3k27me3 antibody, snap-certified™ for cut&run and cut&tag
    A. Locus plot of the silencer s1, located within an intron of ZCCHC24 (hg19: chr10:81,104,100-81,207,000). Close-up shows the ChromBPNet attribution track, annotated TFBS, and Swap-seq edits within s1. Significance determined by one-sample t-test: red, BH-corrected p < 0.001; gray, not significant. Error bars: 95% CI for the mean. B. qPCR quantification of the effects of s1 edits on PPIF and ZCCHC24 gene expression. qPCR was used to measure the change of PPIF and ZCCHC24 gene expression between WT clones and clones carrying a homozygous Swap-seq edit of s1. Each dot represents results from an independent clone, averaged between three qPCR replicates. Error bars: 95% CI for the mean. C. Validation of the silencer by lentiMPRA. The silencer, in both orientations, was paired with three promoters: PPIF , EF1A , and FTH1 . A sequence lacking predicted TFBS (noTFBS) served as a negative control for basal promoter strength. Significance determined by two-sample t-test: *p < 0.05, **p < 0.01, ***p < 0.001. Error bars: 95% CI for the mean. D. Inhibitor treatment of cells with lentiviral fluorescent reporter construct. Cells were treated with the indicated inhibitors over a 5-day time course and assayed on days 0, 2, 3 and 5. Dots show mean fluorescence intensity (MFI), expressed as fold-change over DMSO controls, averaged across 3 biological replicates. Blue, reporter construct with silencer; gray, EF1A promoter-only control. Significance determined by unpaired two-sided Welch’s t-test: *p < 0.05, **p < 0.01, ns, not significant. Error bars: 95% CI for the mean. E. Genomic tracks of accessibility and histone modifications at the silencer s1 locus in WT and clonal lines carrying s1 deletion. Blue, WT; orange, homozygous edited clones. Top to bottom: ATAC-seq (WT, 4 clones; Edited, 6 clones), H3K4me3 CUT&RUN (WT, 3 clones; Edited, 3 clones), <t>H3K27me3</t> CUT&RUN (WT, 6 clones; Edited, 6 clones), and H3K27ac CUT&RUN (WT, 3 clones; Edited, 3 clones). The scale of H3K27me3 is set such that the maximum matches signal at the exemplary locus enriched with this signal (see fig. S9C ). F. Quantification of ATAC-seq and CUT&RUN signal changes between WT and clones with the s1 edit. Significance determined by Wald z-test: *p < 0.05, **p < 0.01, ***p < 0.001, ns, not significant. Peaks with significant changes highlighted in black. Error bars: 95% CI for the mean. G. Model of silencer s1 mechanism. The silencer depends on HDACs to repress nearby enhancers that regulate PPIF and ZCCHC24 . Deletion of the silencer leads to increased enhancer activities, thereby upregulating PPIF and ZCCHC24 .
    H3k27me3 Antibody, Snap Certified™ For Cut&Run And Cut&Tag, supplied by EpiCypher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/13-0055/H3K27me3+Antibody%2C+SNAP-Certified%E2%84%A2+for+CUT%26RUN+and+CUT%26Tag/custom%4013-0055%4010%2E64898%2F2026%2E04%2E14%2E718582
    Average 95 stars, based on 1 article reviews
    h3k27me3 antibody, snap-certified™ for cut&run and cut&tag - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    Image Search Results


    A-D) MTS cell viability assays are presented with viability day +6 from infection normalized to uninfected controls. Error bars represent standard error of the mean for biological replicates, where each experiment utilized N = 6 technical replicates per dose. Blue lines and bars correspond to the H3K27me3-deficient condition. Dose-response curves were fitted via non-linear regression, and IC 50 values were compared using the Extra sum-of-squares F test. A) HSV G47Δ demonstrates significantly greater cytotoxicity against all evaluated human MPNST cell lines compared to hTert -immortalized primary human Schwann cells (iHSC 1L), based on IC 50 comparisons (all p <0.001). The mean IC 50 for every tested MPNST cell line is <0.1 MOI. B) In isogenic models of MPNST derived from hTert -immortalized human Schwann cells, SUZ12 knock-out shifts the IC 50 to the left ( p <0.001). C) PRC2-proficient MPNST724 is further sensitized to HSV G47Δ when H3K27me3 is depleted by pharmacologic pretreatment with valemetostat ( p <0.001), while drug pretreatment did not significantly alter the IC 50 in PRC2-deficient S462-TY ( p =0.8). D) S462-TY was engineered to restore SUZ12 under a doxycycline-inducible TET system (TY5005 is the derivative of parental S462-TY). After genetic rescue restoring H3K27me3, the IC 50 of HSV G47Δ significantly shifted rightward ( p <0.001). E) Equally seeded MPNST724 (valemetostat pretreated vs. wildtype) and TY5005 (doxycycline induced vs. wildtype) were infected at 0.01 MOI. Adherent cells were collected at indicated time points, and the percentage of β-galactosidase positive cells was quantified by flow cytometry. Kinetics of HSV G47Δ spread were significantly increased in the H3K27me3-deficient context. By 72 hours, 100% infection coverage was observed in the H3K27me3-deficient condition compared to approximately 10% in the PRC2-proficient condition. Error bars represent SEM for three biological replicates. Statistical significance between PRC2-proficient and deficient conditions at each timepoint was determined using Welch’s t-tests, with p-values adjusted for multiple comparisons (BH procedure) [*: p ≤0.05; **: p ≤0.01; ***: p ≤0.001; ****: p ≤0.0001].

    Journal: bioRxiv

    Article Title: Biomarker-driven and gene-enhanced viral therapy for malignant peripheral nerve sheath tumor

    doi: 10.64898/2026.10.12.758653

    Figure Lengend Snippet: A-D) MTS cell viability assays are presented with viability day +6 from infection normalized to uninfected controls. Error bars represent standard error of the mean for biological replicates, where each experiment utilized N = 6 technical replicates per dose. Blue lines and bars correspond to the H3K27me3-deficient condition. Dose-response curves were fitted via non-linear regression, and IC 50 values were compared using the Extra sum-of-squares F test. A) HSV G47Δ demonstrates significantly greater cytotoxicity against all evaluated human MPNST cell lines compared to hTert -immortalized primary human Schwann cells (iHSC 1L), based on IC 50 comparisons (all p <0.001). The mean IC 50 for every tested MPNST cell line is <0.1 MOI. B) In isogenic models of MPNST derived from hTert -immortalized human Schwann cells, SUZ12 knock-out shifts the IC 50 to the left ( p <0.001). C) PRC2-proficient MPNST724 is further sensitized to HSV G47Δ when H3K27me3 is depleted by pharmacologic pretreatment with valemetostat ( p <0.001), while drug pretreatment did not significantly alter the IC 50 in PRC2-deficient S462-TY ( p =0.8). D) S462-TY was engineered to restore SUZ12 under a doxycycline-inducible TET system (TY5005 is the derivative of parental S462-TY). After genetic rescue restoring H3K27me3, the IC 50 of HSV G47Δ significantly shifted rightward ( p <0.001). E) Equally seeded MPNST724 (valemetostat pretreated vs. wildtype) and TY5005 (doxycycline induced vs. wildtype) were infected at 0.01 MOI. Adherent cells were collected at indicated time points, and the percentage of β-galactosidase positive cells was quantified by flow cytometry. Kinetics of HSV G47Δ spread were significantly increased in the H3K27me3-deficient context. By 72 hours, 100% infection coverage was observed in the H3K27me3-deficient condition compared to approximately 10% in the PRC2-proficient condition. Error bars represent SEM for three biological replicates. Statistical significance between PRC2-proficient and deficient conditions at each timepoint was determined using Welch’s t-tests, with p-values adjusted for multiple comparisons (BH procedure) [*: p ≤0.05; **: p ≤0.01; ***: p ≤0.001; ****: p ≤0.0001].

    Article Snippet: Concanavalin-A-immobilized nuclei (EpiCypher #21-1401) were incubated overnight at 4 °C with antibodies against H3K27me3 (EpiCypher #13-0055), H3K4me3 (EpiCypher #13-0060), or matched IgG control (EpiCypher #13-0042); DNA methylation was profiled using recombinant GST-MeCP2 (EpiCypher #15-2002) followed by anti-GST targeting (EpiCypher #13-0073).

    Techniques: Infection, Derivative Assay, Knock-Out, Flow Cytometry

    A) Schematic representation of the proposed viral silencing mechanism, wherein the host Polycomb Repressive Complex 2 (PRC2) deposits H3K27me3 on host histones associated with viral DNA, reducing RNA polymerase II (RNAPII) transcription. B) Excess total cell H3K27me3 immunoblotting is observed in doxycycline-induced TY5005 (TY/Dox) at 24 hours post-infection (left). Similarly, excess H3K27me3 is observed in the infected PRC2-proficient N0(32.1) at both 12 and 24 hours post-infection (right). C-D) CUT&RUN analysis of H3K27me3 occupancy on the human genome (C) and HSV-1 episome (D) in TY5005 with or without SUZ12 genetic rescue. Y-axes represent total H3K27me3 genomic occupancy, normalized to an E. coli spike-in control and mathematically background-subtracted against matched IgG negative controls (H3K27me3 - IgG). Statistical significance was determined using a Two-Way ANOVA followed by post-hoc pairwise comparisons via estimated marginal means [***: p ≤0.001; ns: not significant]. C) Quantification of H3K27me3 on the human genome confirms successful doxycycline induction of global H3K27me3, with no significant difference observed in host genome deposition between uninfected and infected TY5005/Dox biological replicates. D) H3K27me3 accumulation on the HSV-1 genome was detected specifically after PRC2 rescue, consistent with PRC2-dependent chromatinization of viral DNA. E) Representative track plot visualizing H3K27me3 occupancy across the HSV-1 genome (GU734771.1) for the conditions evaluated in panel D. Robust, widespread H3K27me3 deposition is visible across the viral episome strictly in the TY5005 + Dox + HSV condition. Regions lacking signal correspond to HSV-1 repeat regions that are excluded in multimapping alignment filtering.

    Journal: bioRxiv

    Article Title: Biomarker-driven and gene-enhanced viral therapy for malignant peripheral nerve sheath tumor

    doi: 10.64898/2026.10.12.758653

    Figure Lengend Snippet: A) Schematic representation of the proposed viral silencing mechanism, wherein the host Polycomb Repressive Complex 2 (PRC2) deposits H3K27me3 on host histones associated with viral DNA, reducing RNA polymerase II (RNAPII) transcription. B) Excess total cell H3K27me3 immunoblotting is observed in doxycycline-induced TY5005 (TY/Dox) at 24 hours post-infection (left). Similarly, excess H3K27me3 is observed in the infected PRC2-proficient N0(32.1) at both 12 and 24 hours post-infection (right). C-D) CUT&RUN analysis of H3K27me3 occupancy on the human genome (C) and HSV-1 episome (D) in TY5005 with or without SUZ12 genetic rescue. Y-axes represent total H3K27me3 genomic occupancy, normalized to an E. coli spike-in control and mathematically background-subtracted against matched IgG negative controls (H3K27me3 - IgG). Statistical significance was determined using a Two-Way ANOVA followed by post-hoc pairwise comparisons via estimated marginal means [***: p ≤0.001; ns: not significant]. C) Quantification of H3K27me3 on the human genome confirms successful doxycycline induction of global H3K27me3, with no significant difference observed in host genome deposition between uninfected and infected TY5005/Dox biological replicates. D) H3K27me3 accumulation on the HSV-1 genome was detected specifically after PRC2 rescue, consistent with PRC2-dependent chromatinization of viral DNA. E) Representative track plot visualizing H3K27me3 occupancy across the HSV-1 genome (GU734771.1) for the conditions evaluated in panel D. Robust, widespread H3K27me3 deposition is visible across the viral episome strictly in the TY5005 + Dox + HSV condition. Regions lacking signal correspond to HSV-1 repeat regions that are excluded in multimapping alignment filtering.

    Article Snippet: Concanavalin-A-immobilized nuclei (EpiCypher #21-1401) were incubated overnight at 4 °C with antibodies against H3K27me3 (EpiCypher #13-0055), H3K4me3 (EpiCypher #13-0060), or matched IgG control (EpiCypher #13-0042); DNA methylation was profiled using recombinant GST-MeCP2 (EpiCypher #15-2002) followed by anti-GST targeting (EpiCypher #13-0073).

    Techniques: Western Blot, Infection, Analysis, Control

    A) Schematic representation of the integrated stress response. Viral double-stranded RNA (dsRNA) can activate PKR, leading to phosphorylation of eIF2α and suppression of global translation initiation. ATF4 is preferentially translated during eIF2α phosphorylation and promotes downstream apoptotic transcriptional programs, while recovery is mediated by GADD34-mediated restoration of eIF2α activity. B) Ratio of phosphorylated to total eIF2α in each PRC2 modular system following HSV infection, determined by immunoblotting in n =2 independent biological replicates per indicated time point and normalized to matched uninfected controls. Error bars indicate the range between independent experiments. HSV infection increased p-eIF2α:eIF2α across the evaluated models, consistent with activation of the eIF2α stress-response axis. No significant differences were detected between H3K27me3-deficient and proficient states at the evaluated time points (Welch’s two-sample t -test; ns), although this study was not powered to detect subtle differences . C–E) Transcriptomic responses to HSV were evaluated across the three PRC2 modular systems (n=6 biological replicates per PRC2-status and infection condition). Because viral replication kinetics differed by PRC2 phenotype, infected samples were harvested at a matched stage of viral spread (>80% β-galactosidase-positive cells), with corresponding time-matched uninfected controls. C) Focused FGSEA of IFN-α response, ISR, and apoptosis pathways in PRC2-deficient versus proficient cells within the uninfected and infected states. Positive normalized enrichment scores indicate enrichment in the PRC2-deficient phenotype. Bars represent FGSEA normalized enrichment scores; significance annotations reflect BH-adjusted q- values from the corresponding system-adjusted sample-level ssGSEA models using HC3 robust covariance estimates [***, q <0.001]. PRC2-deficient cells demonstrate elevated baseline activity of these antiviral/stress-response programs that persists during productive HSV infection. D) Sample-level ISR score, calculated as the mean variance-stabilized expression of genes within the GO ISR pathway. Estimates were obtained from a factorial linear model adjusting for model system and incorporating PRC2 status, infection, and their interaction with HC3 robust covariance estimates. Among uninfected cells, PRC2 deficiency was associated with a +0.14 VST-unit increase in ISR score ( p <0.001; partial η²=0.55). Among PRC2-proficient cells, HSV infection increased the ISR score by +0.15 VST units ( p <0.001; partial η²=0.56). A positive PRC2 × infection interaction (+0.20 VST, p <0.001; partial η² = 0.17) indicated a greater infection-associated ISR increase in PRC2-deficient cells. The adjusted contrast between proficient/uninfected and deficient/infected states was +0.49 VST units ( p <0.001; Cohen’s d = 4.27). E) Global Translation/RNA activity index, representing the mean of z-standardized ssGSEA scores across MSigDB pathways associated with translation, ribosome biogenesis, and RNA processing. Estimates were obtained from a factorial linear model with HC3 robust covariance. HSV infection increased the index in PRC2-proficient cells (+0.54 units, p <0.001) but not significantly in PRC2-deficient cells (+0.09 units, p =0.27). The PRC2 × infection interaction was negative (−0.45, p <0.001), consistent with blunted infection-associated transcriptional induction of translation/RNA-associated programs in the PRC2-deficient state. F) Representative immunohistochemistry of an HSV G47Δ-treated S462-TY xenograft demonstrating limited viral distribution. β-galactosidase staining (brown) was concentrated near the central necrotic region, with patchy signal throughout the remaining viable tumor. Scale bar = 5 mm.

    Journal: bioRxiv

    Article Title: Biomarker-driven and gene-enhanced viral therapy for malignant peripheral nerve sheath tumor

    doi: 10.64898/2026.10.12.758653

    Figure Lengend Snippet: A) Schematic representation of the integrated stress response. Viral double-stranded RNA (dsRNA) can activate PKR, leading to phosphorylation of eIF2α and suppression of global translation initiation. ATF4 is preferentially translated during eIF2α phosphorylation and promotes downstream apoptotic transcriptional programs, while recovery is mediated by GADD34-mediated restoration of eIF2α activity. B) Ratio of phosphorylated to total eIF2α in each PRC2 modular system following HSV infection, determined by immunoblotting in n =2 independent biological replicates per indicated time point and normalized to matched uninfected controls. Error bars indicate the range between independent experiments. HSV infection increased p-eIF2α:eIF2α across the evaluated models, consistent with activation of the eIF2α stress-response axis. No significant differences were detected between H3K27me3-deficient and proficient states at the evaluated time points (Welch’s two-sample t -test; ns), although this study was not powered to detect subtle differences . C–E) Transcriptomic responses to HSV were evaluated across the three PRC2 modular systems (n=6 biological replicates per PRC2-status and infection condition). Because viral replication kinetics differed by PRC2 phenotype, infected samples were harvested at a matched stage of viral spread (>80% β-galactosidase-positive cells), with corresponding time-matched uninfected controls. C) Focused FGSEA of IFN-α response, ISR, and apoptosis pathways in PRC2-deficient versus proficient cells within the uninfected and infected states. Positive normalized enrichment scores indicate enrichment in the PRC2-deficient phenotype. Bars represent FGSEA normalized enrichment scores; significance annotations reflect BH-adjusted q- values from the corresponding system-adjusted sample-level ssGSEA models using HC3 robust covariance estimates [***, q <0.001]. PRC2-deficient cells demonstrate elevated baseline activity of these antiviral/stress-response programs that persists during productive HSV infection. D) Sample-level ISR score, calculated as the mean variance-stabilized expression of genes within the GO ISR pathway. Estimates were obtained from a factorial linear model adjusting for model system and incorporating PRC2 status, infection, and their interaction with HC3 robust covariance estimates. Among uninfected cells, PRC2 deficiency was associated with a +0.14 VST-unit increase in ISR score ( p <0.001; partial η²=0.55). Among PRC2-proficient cells, HSV infection increased the ISR score by +0.15 VST units ( p <0.001; partial η²=0.56). A positive PRC2 × infection interaction (+0.20 VST, p <0.001; partial η² = 0.17) indicated a greater infection-associated ISR increase in PRC2-deficient cells. The adjusted contrast between proficient/uninfected and deficient/infected states was +0.49 VST units ( p <0.001; Cohen’s d = 4.27). E) Global Translation/RNA activity index, representing the mean of z-standardized ssGSEA scores across MSigDB pathways associated with translation, ribosome biogenesis, and RNA processing. Estimates were obtained from a factorial linear model with HC3 robust covariance. HSV infection increased the index in PRC2-proficient cells (+0.54 units, p <0.001) but not significantly in PRC2-deficient cells (+0.09 units, p =0.27). The PRC2 × infection interaction was negative (−0.45, p <0.001), consistent with blunted infection-associated transcriptional induction of translation/RNA-associated programs in the PRC2-deficient state. F) Representative immunohistochemistry of an HSV G47Δ-treated S462-TY xenograft demonstrating limited viral distribution. β-galactosidase staining (brown) was concentrated near the central necrotic region, with patchy signal throughout the remaining viable tumor. Scale bar = 5 mm.

    Article Snippet: Concanavalin-A-immobilized nuclei (EpiCypher #21-1401) were incubated overnight at 4 °C with antibodies against H3K27me3 (EpiCypher #13-0055), H3K4me3 (EpiCypher #13-0060), or matched IgG control (EpiCypher #13-0042); DNA methylation was profiled using recombinant GST-MeCP2 (EpiCypher #15-2002) followed by anti-GST targeting (EpiCypher #13-0073).

    Techniques: Phospho-proteomics, Activity Assay, Infection, Western Blot, Activation Assay, Expressing, Immunohistochemistry, Xenograft Assay, Staining

    A. Locus plot of the silencer s1, located within an intron of ZCCHC24 (hg19: chr10:81,104,100-81,207,000). Close-up shows the ChromBPNet attribution track, annotated TFBS, and Swap-seq edits within s1. Significance determined by one-sample t-test: red, BH-corrected p < 0.001; gray, not significant. Error bars: 95% CI for the mean. B. qPCR quantification of the effects of s1 edits on PPIF and ZCCHC24 gene expression. qPCR was used to measure the change of PPIF and ZCCHC24 gene expression between WT clones and clones carrying a homozygous Swap-seq edit of s1. Each dot represents results from an independent clone, averaged between three qPCR replicates. Error bars: 95% CI for the mean. C. Validation of the silencer by lentiMPRA. The silencer, in both orientations, was paired with three promoters: PPIF , EF1A , and FTH1 . A sequence lacking predicted TFBS (noTFBS) served as a negative control for basal promoter strength. Significance determined by two-sample t-test: *p < 0.05, **p < 0.01, ***p < 0.001. Error bars: 95% CI for the mean. D. Inhibitor treatment of cells with lentiviral fluorescent reporter construct. Cells were treated with the indicated inhibitors over a 5-day time course and assayed on days 0, 2, 3 and 5. Dots show mean fluorescence intensity (MFI), expressed as fold-change over DMSO controls, averaged across 3 biological replicates. Blue, reporter construct with silencer; gray, EF1A promoter-only control. Significance determined by unpaired two-sided Welch’s t-test: *p < 0.05, **p < 0.01, ns, not significant. Error bars: 95% CI for the mean. E. Genomic tracks of accessibility and histone modifications at the silencer s1 locus in WT and clonal lines carrying s1 deletion. Blue, WT; orange, homozygous edited clones. Top to bottom: ATAC-seq (WT, 4 clones; Edited, 6 clones), H3K4me3 CUT&RUN (WT, 3 clones; Edited, 3 clones), H3K27me3 CUT&RUN (WT, 6 clones; Edited, 6 clones), and H3K27ac CUT&RUN (WT, 3 clones; Edited, 3 clones). The scale of H3K27me3 is set such that the maximum matches signal at the exemplary locus enriched with this signal (see fig. S9C ). F. Quantification of ATAC-seq and CUT&RUN signal changes between WT and clones with the s1 edit. Significance determined by Wald z-test: *p < 0.05, **p < 0.01, ***p < 0.001, ns, not significant. Peaks with significant changes highlighted in black. Error bars: 95% CI for the mean. G. Model of silencer s1 mechanism. The silencer depends on HDACs to repress nearby enhancers that regulate PPIF and ZCCHC24 . Deletion of the silencer leads to increased enhancer activities, thereby upregulating PPIF and ZCCHC24 .

    Journal: bioRxiv

    Article Title: Systematic mapping of enhancers, silencers, and topological elements with prime editing deletion screens

    doi: 10.64898/2026.10.08.756856

    Figure Lengend Snippet: A. Locus plot of the silencer s1, located within an intron of ZCCHC24 (hg19: chr10:81,104,100-81,207,000). Close-up shows the ChromBPNet attribution track, annotated TFBS, and Swap-seq edits within s1. Significance determined by one-sample t-test: red, BH-corrected p < 0.001; gray, not significant. Error bars: 95% CI for the mean. B. qPCR quantification of the effects of s1 edits on PPIF and ZCCHC24 gene expression. qPCR was used to measure the change of PPIF and ZCCHC24 gene expression between WT clones and clones carrying a homozygous Swap-seq edit of s1. Each dot represents results from an independent clone, averaged between three qPCR replicates. Error bars: 95% CI for the mean. C. Validation of the silencer by lentiMPRA. The silencer, in both orientations, was paired with three promoters: PPIF , EF1A , and FTH1 . A sequence lacking predicted TFBS (noTFBS) served as a negative control for basal promoter strength. Significance determined by two-sample t-test: *p < 0.05, **p < 0.01, ***p < 0.001. Error bars: 95% CI for the mean. D. Inhibitor treatment of cells with lentiviral fluorescent reporter construct. Cells were treated with the indicated inhibitors over a 5-day time course and assayed on days 0, 2, 3 and 5. Dots show mean fluorescence intensity (MFI), expressed as fold-change over DMSO controls, averaged across 3 biological replicates. Blue, reporter construct with silencer; gray, EF1A promoter-only control. Significance determined by unpaired two-sided Welch’s t-test: *p < 0.05, **p < 0.01, ns, not significant. Error bars: 95% CI for the mean. E. Genomic tracks of accessibility and histone modifications at the silencer s1 locus in WT and clonal lines carrying s1 deletion. Blue, WT; orange, homozygous edited clones. Top to bottom: ATAC-seq (WT, 4 clones; Edited, 6 clones), H3K4me3 CUT&RUN (WT, 3 clones; Edited, 3 clones), H3K27me3 CUT&RUN (WT, 6 clones; Edited, 6 clones), and H3K27ac CUT&RUN (WT, 3 clones; Edited, 3 clones). The scale of H3K27me3 is set such that the maximum matches signal at the exemplary locus enriched with this signal (see fig. S9C ). F. Quantification of ATAC-seq and CUT&RUN signal changes between WT and clones with the s1 edit. Significance determined by Wald z-test: *p < 0.05, **p < 0.01, ***p < 0.001, ns, not significant. Peaks with significant changes highlighted in black. Error bars: 95% CI for the mean. G. Model of silencer s1 mechanism. The silencer depends on HDACs to repress nearby enhancers that regulate PPIF and ZCCHC24 . Deletion of the silencer leads to increased enhancer activities, thereby upregulating PPIF and ZCCHC24 .

    Article Snippet: We followed the standard protocol for CUT&RUN experiments targeting H3K27me3 (Antibody: EpiCypher 13-0055) and H3K4me3 (Antibody: EpiCypher 13-0060), using Rabbit IgG (Antibody: EpiCypher 13-0042) as a negative control.

    Techniques: Gene Expression, Clone Assay, Biomarker Discovery, Sequencing, Negative Control, Construct, Fluorescence, Control